Pathstone Holdings’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Sell
6,501
-294
-4% -$20K ﹤0.01% 1924
2026
Q1
$513K Buy
+6,795
New +$557K ﹤0.01% 1740
2025
Q4
Sell
-6,441
Closed -$547K 2393
2025
Q3
$547K Buy
6,441
+330
+5% +$26.4K ﹤0.01% 1726
2025
Q2
$478K Sell
6,111
-1,063
-15% -$78.4K ﹤0.01% 1741
2025
Q1
$522K Sell
7,174
-929
-11% -$77.9K ﹤0.01% 1694
2024
Q4
$719K Sell
8,103
-417
-5% -$37.2K ﹤0.01% 1543
2024
Q3
$721K Buy
8,520
+134
+2% +$11.9K ﹤0.01% 1539
2024
Q2
$775K Buy
8,386
+586
+8% +$59.3K ﹤0.01% 1457
2024
Q1
$883K Sell
7,800
-176
-2% -$17.6K ﹤0.01% 1360
2023
Q4
$743K Buy
+7,976
New +$702K ﹤0.01% 1255

Other funds holding USPH

Pathstone Holdings's USPH Position: Q2 2026 in Review

Pathstone Holdings reduced its US Physical Therapy (USPH) stake by 4.3% in Q2 2026, selling an estimated $20K and leaving 6,501 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

Pathstone Holdings first reported a position in USPH in Q4 2023 and has held it in 10 quarters since. The position peaked at $883K in Q1 2024. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Pathstone Holdings held 6,501 shares of US Physical Therapy worth $446K as of Q2 2026.
  • Pathstone Holdings sold 294 US Physical Therapy shares in Q2 2026, an estimated $20K.
  • US Physical Therapy made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1924 holding.
  • Pathstone Holdings first reported a position in US Physical Therapy in Q4 2023 and has held it in 10 quarters since.
  • Pathstone Holdings's US Physical Therapy position peaked at $883K in Q1 2024.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.